ST MORIZ SUNCARE FACE SUNSCREEN SPF50- octocrylene, octisalate , avobenzone , homosalate lotion

St Moriz suncare face sunscreen spf50 by

Drug Labeling and Warnings

St Moriz suncare face sunscreen spf50 by is a Otc medication manufactured, distributed, or labeled by Aopline Biotechnology (Guangzhou) Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

OCTOCRYLENE
OCTISALATE
AVOBENZONE
HOMOSALATE

PURPOSE

Sunscreen

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children . If product is swallowed , get medical help or contact a
Poison Control Center right away

WARNINGS

For external use only .
Do not use on broken or damaged skin .
Stop use and ask a doctor if rash occurs
When using this product keep out of eyes . Rinse with water to remove .
Keep out of reach of children . If product is swallowed , get medical help or contact a
Poison Control Center right away .

DOSAGE & ADMINISTRATION

INDICATIONS & USAGE

Directions : Apply liberally 15 minutes before sun or water exposure. Works best on
moisturized skin.
Reapply:
After 80 minutes of swimming or sweating.
Immediately after towel drying.
At least every 2 hours.
Children under 6 months: Ask a doctor..

INACTIVE INGREDIENT

BUTYLENE GLYCOL
WATER
C14-22 ALCOHOLS
C12-20 ALKYL GLUCOSIDE
BUTYLOCTYL SALICYLATE
STEARETH-21
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER
POLYSORBATE 60
SORBITAN ISOSTEARATE
TREHALOSE
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER
SILICA
PHENOXYETHANOL
CHLORPHENESIN
FRAGRANCE
DISODIUM EDTA
PANTHENOL
ALOE BARBADENSIS LEAF WATER

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

ST MORIZ SUNCARE FACE SUNSCREEN SPF50 
octocrylene, octisalate , avobenzone , homosalate lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87283-007
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	16.2 g  in 180 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	5.4 g  in 180 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W)	OCTISALATE	7.2 g  in 180 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	9 g  in 180 mL

Inactive Ingredients
Ingredient Name	Strength
C14-22 ALCOHOLS (UNII: B1K89384RJ)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
CHLORPHENESIN (UNII: I670DAL4SZ)
ALOE BARBADENSIS LEAF POWDER (UNII: ZY81Z83H0X)
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)
TREHALOSE (UNII: B8WCK70T7I)
SILICA (UNII: ETJ7Z6XBU4)
STEARETH-21 (UNII: 53J3F32P58)
SORBITAN ISOSTEARATE (UNII: 01S2G2C1E4)
PANTHENOL (UNII: WV9CM0O67Z)
C12-20 ALKYL GLUCOSIDE (UNII: K67N5Z1RUA)
EDETATE DISODIUM (UNII: 7FLD91C86K)
WATER (UNII: 059QF0KO0R)
POLYSORBATE 60 (UNII: CAL22UVI4M)
BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)
PHENOXYETHANOL (UNII: HIE492ZZ3T)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87283-007-01	180 mL in 1 BOTTLE; Type 0: Not a Combination Product	01/08/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	01/08/2026

Labeler - Aopline Biotechnology (Guangzhou) Co., Ltd. (514879104)